These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4295475)

  • 1. The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity.
    Schein PS; Cooney DA; Vernon ML
    Cancer Res; 1967 Dec; 27(12):2324-32. PubMed ID: 4295475
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptozotocin diabetes in monkeys and dogs, and its prevention by nicotinamide.
    Schein PS; Rakieten N; Cooney DA; Davis R; Vernon ML
    Proc Soc Exp Biol Med; 1973 Jun; 143(2):514-8. PubMed ID: 4267772
    [No Abstract]   [Full Text] [Related]  

  • 3. [Streptozotocin].
    Rudas B
    Arzneimittelforschung; 1972 May; 22(5):830-61. PubMed ID: 4340253
    [No Abstract]   [Full Text] [Related]  

  • 4. The uptake in the pancreatic islets of nicotinamide, nicotinic acid and tryptophan and their ability to prevent streptozotocin diabetes in mice.
    Tjälve H; Wilander E
    Acta Endocrinol (Copenh); 1976 Oct; 83(2):357-64. PubMed ID: 135465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.
    Anderson T; Schein PS; McMenamin MG; Cooney DA
    J Clin Invest; 1974 Sep; 54(3):672-7. PubMed ID: 4369217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitotic activity of islet cells in alloxan and streptozotocin diabetic mice studies by radioautography.
    Logothetopoulos J; Brosky G
    Diabetes; 1968; 17():306. PubMed ID: 4870770
    [No Abstract]   [Full Text] [Related]  

  • 7. Streptozotocin diabetes--further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver.
    Schein PS; Cooney DA; McMenamin MG; Anderson T
    Biochem Pharmacol; 1973 Oct; 22(20):2625-31. PubMed ID: 4357891
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of nicotinamide and pyridine nucleotides on streptozotocin and alloxan-induced pancreatic B cell cytotoxicity.
    Lazarus SS; Shapiro SH
    Diabetes; 1973 Jul; 22(7):499-506. PubMed ID: 4146293
    [No Abstract]   [Full Text] [Related]  

  • 9. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
    Hassan N; Janjua MZ
    J Ayub Med Coll Abbottabad; 2001; 13(3):26-30. PubMed ID: 11873395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma glucose levels in normal and adrenalectomized mice treated with streptozotocin and nicotinamide.
    Schein PS; Bates RW
    Diabetes; 1968 Dec; 17(12):760-5. PubMed ID: 4235759
    [No Abstract]   [Full Text] [Related]  

  • 11. Nicotinamide and streptozotocin diabetes in the rat. Factors influencing the effectiveness of the protection.
    Masiello P; Bergamini E
    Experientia; 1977 Sep; 33(9):1246-7. PubMed ID: 142654
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal of streptozotocin diabetes with nicotinamide.
    Dulin WE; Wyse BM
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):992-4. PubMed ID: 4304354
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of the diabetogenic action of streptozotocin.
    Junod A; Lambert AE; Orci L; Pictet R; Gonet AE; Renold AE
    Proc Soc Exp Biol Med; 1967 Oct; 126(1):201-5. PubMed ID: 4864021
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of nicotinamide on experimental induced diabetes.
    Alenzi FQ
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):11-8. PubMed ID: 19279354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic effect through islet cell protection in streptozotocin diabetes: a preliminary assessment of two thiazolidin-4-ones in Swiss albino mice.
    Kishore A; Nampurath GK; Mathew SP; Zachariah RT; Potu BK; Rao MS; Valiathan M; Chamallamudi MR
    Chem Biol Interact; 2009 Feb; 177(3):242-6. PubMed ID: 19038238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
    Piercy V; Toseland CD; Turner NC
    Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of alpha-tocopherol acetate and nicotinamide at the onset of insulin dependent diabetes mellitus].
    Dedov II; Gorelysheva VA; Romanovskaia GA; Filippov IK; Smirnova OM
    Klin Med (Mosk); 1995; 73(6):40-3. PubMed ID: 8691780
    [No Abstract]   [Full Text] [Related]  

  • 19. Nicotinamide: potential for the prevention of type 1 diabetes?
    Gale EA
    Horm Metab Res; 1996 Jul; 28(7):361-4. PubMed ID: 8858387
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.